Unexpectedly, repeated treatment with 17 (R) HDoHE did not modify paw and joint oedema in the sub-chronic model, while joint stiffness was prevented.
AT-RvD1 exhibited marked anti-hyperalgesic effects in acute inflammation when given systemically.